Healthcare -
Biotechnology - NASDAQ - US
$ 1.9
-1.04 %
$ 398 M
Market Cap
-1.23
P/E
ALLO - FREE CASH FLOW
Free Cash Flow ALLO - Allogene Therapeutics, Inc.
-239 M
LAST VALUE
-7.70%
2 YEAR CAGR
-37.95%
5 YEAR CAGR
0.00%
10 YEAR CAGR